Skip to main content

Advertisement

Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy

Fig. 3

MSC administration reduces liver injury after 70% hepatectomy. Plasmatic levels of hepatocellular damage markers (a) aspartate aminotransferase and (b) alanine aminotransferase and hepatocyte function (c) prothrombin were determined 2 and 7 days after surgery. All data are presented as mean ± SEM (n = 8), a p < 0.05 vs. normal pre-Hpx; b p < 0.05 vs. normal + Vh; c p < 0.05 vs. obese pre-Hpx and d p < 0.05 vs. obese + Vh

Back to article page